Breakthroughs in artificial intelligence and neurotechnology are revolutionizing healthcare, enabling people with debilitating diseases to communicate in ways previously impossible. Implantable devices like the Stentrode, developed by Synchron, can translate brain signals into physical actions, giving patients like Rodney, who has ALS, the ability to type using only his thoughts. As the neurotech market grows, projected to reach $55 billion by 2032, companies like Meta and Apple are investing in non-invasive devices to decode thoughts and perceptions, but concerns over mental privacy are driving calls for regulation and policy change.